Evidence map›Paper›PMID 41291571›Full record

ArticleBMC ophthalmology2025

Beauveria bassiana keratitis - the first Hungarian case report.

Tibor Rák, Renáta Hargitai, Ágnes Sonnevend, Adrienne Csutak, Eszter Szalai

Abstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tibor RákMedical School, Clinical Center, Department of Ophthalmology, University of Pécs, Rákóczi Street 2, Pécs, 7624, Hungary. rak.tibor@pte.hu.
Renáta HargitaiMedical School, Institute of Medical Microbiology and Immunology, University of Pécs, Szigeti Street 12, Pécs, 7624, Hungary.
Ágnes SonnevendMedical School, Institute of Medical Microbiology and Immunology, University of Pécs, Szigeti Street 12, Pécs, 7624, Hungary.
Adrienne CsutakMedical School, Clinical Center, Department of Ophthalmology, University of Pécs, Rákóczi Street 2, Pécs, 7624, Hungary.
Eszter SzalaiMedical School, Clinical Center, Department of Ophthalmology, University of Pécs, Rákóczi Street 2, Pécs, 7624, Hungary.

Funding

University Research Scholarship Program (EKÖP) EKÖP-24-4-I-PTE-170
6 · The paper itself

Abstract

The Beauveria bassiana-induced fungal keratitis is a rare but severe ocular infection that may result in significant vision impairment without proper treatment. Here we present a case of a 46-year-old Hungarian male patient who developed keratitis following contact lens use and gardening activities. The patient's medical history included hypertension and type 2 diabetes, which may have contributed to the infection's onset. Clinical examination revealed severe vision loss, pain, and photophobia, with signs indicative of corneal hyphal infection. Microbiological tests confirmed the presence of B. bassiana, identified using MALDI-TOF MS techniques. Following the failure of initial antibiotic treatment, local antifungal therapy (nystatin eye ointment and propamidine isethionate eye drops) was administered, resulting in significant vision improvement over three months. Timely recognition and targeted treatment of B. bassiana keratitis are crucial for successful disease management. The significance of this case lies in the fact that this pathogen has not been previously documented in Hungary, highlighting the diagnostic and therapeutic challenges of rare opportunistic fungal infections.

Indexed as

BeauveriaEye Infections, FungalKeratitisAntifungal AgentsHumansHungaryMaleMiddle AgedAntifungal AgentsAntifungal therapyBeauveria bassianaEntomopathogenicFungal keratitisIn vivo confocal microscopy

Identifiers

PMID41291571
PMCPMC12649018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.